A hands-off approach may be more successful in treating chronic hand eczema

Affiliations

Comment

L C Strowd et al. Br J Dermatol. 2020 May.

. 2020 May;182(5):1078.

doi: 10.1111/bjd.18617. Epub 2019 Nov 20.

¹ Department of Dermatology, Wake Forest School of Medicine, 4618 Country Club Road, Winston-Salem, NC, 27104, U.S.A.

No abstract available

Comment on

Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study.
Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TSS. Worm M, et al. Br J Dermatol. 2020 May;182(5):1103-1110. doi: 10.1111/bjd.18469. Epub 2019 Nov 8. Br J Dermatol. 2020. PMID: 31466119 Clinical Trial.

1. He H, Guttman-Yassky E. JAK inhibitors for atopic dermatitis: an update. Am J Clin Dermatol 2019; 20:181-92.
1. Worm M, Bauer A, Elsner P et al. Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study. Br J Dermatol 2020; https://doi.org/10.1111/bjd.18469. [Epub ahead of print].
1. Snyder A, Farhangian M, Feldman SR. A review of patient adherence to topical therapies for treatment of atopic dermatitis. Cutis 2015; 96:397-401.
1. Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol 2017; 153:1036-42.
1. Hanifin JM, Ling MR, Langley R et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 2001; 44 (1 Suppl.):S28-38.